(Q51059315)

27 March 2018

title

Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. (English)

1 reference

27 March 2018

0 references

1 reference

J M Flack

1

1 reference

27 March 2018

J D Neaton

series ordinal

2

1 reference

27 March 2018

B Daniels

series ordinal

3

1 reference

27 March 2018

P Esunge

series ordinal

4

1 reference

27 March 2018

publication date

1 April 1993

1 reference

27 March 2018

American Journal of Kidney Diseases

published in

1 reference

27 March 2018

volume

21

1 reference

27 March 2018

issue

4 Suppl 1

1 reference

27 March 2018

page(s)

31-40

1 reference

27 March 2018

Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Renal insufficiency in treated essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Does a renal vasodilator system mediate racial differences in essential hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Renal Vasculature in Essential Hypertension: Racial Differences

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Renal protective effect of strict blood pressure control with enalapril therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

The value of aggressive therapy in the hypertensive patient with azotemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Progression of renal insufficiency: role of blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Black-white differences in blood pressure among participants in NHANES II: the contribution of blood lead

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Chronic low-level lead exposure. Its role in the pathogenesis of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Financial cost as an obstacle to hypertension therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Changing patterns of end-stage renal disease due to hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

US minority groups and end-stage renal disease: a disproportionate share

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). The Multiple Risk Factor Intervention Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Recruitment of participants for the multiple risk factor intervention trial (MRFIT)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Background and design of the new U.S. trial on diet and drug treatment of "mild" hypertension (TOMHS)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Characteristics of participants at baseline in the Treatment of Mild Hypertension Study (TOMHS)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Effects of propranolol therapy on renal function and body fluid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Renin, aldosterone, sodium and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Letter: Racial disparity of plasma volume in hypertensive man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

Prognosis and predisposing factors for essential malignant hypertension in predominantly black patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980859-6

7 January 2021

10.1016/S0272-6386(12)80859-6

Identifiers

DOI

0 references

1 reference

27 March 2018